Navigation Links
Rafarma Pharmaceuticals, Inc. (RAFA) Joins in Economic Development Coalition to Increase Biotech Growth in Terbuny, Russia.
Date:11/11/2013

n>Russia's pharmaceutical industry.

For more information on Rafarma Pharmaceuticals, visit: http://www.rafarma.com

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance.

RELATED LINKS
Website: www.Rafarma.com
Facebook: www.facebook.com/Rafarmainfo
Twitter: www.twitter.com/Rafarmainfo

Contact:
David Anderson
1-801-210-7135
info@rafarma.com


'/>"/>
SOURCE Rafarma Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
2. Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
3. Rafarma Pharmaceuticals, Inc. (RAFA) announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing.
4. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
5. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
9. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
10. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
11. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... N.J. , July 25, 2014  Acsis ... brand protection and serialization solutions, has recently posted ... that addresses current and future needs for ... for the old supply chain model no longer ... in technology, including the growth of mobile technology, ...
(Date:7/25/2014)... Laboratories, Inc. (NASDAQ: IDXX ) today reported ... 11% versus the prior year period to $390 million. ... of 2014 versus the prior year period was 9%, ... . Earnings per diluted share ("EPS") for the quarter ... year period to $1.10."In the second quarter, we continued ...
(Date:7/25/2014)... DIEGO , July 25, 2014  Arena Pharmaceuticals, ... will provide a corporate update and report second quarter ... opens on Friday, August 1, 2014. That same day, ... 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). ... dialing 877.643.7155 for domestic callers and 914.495.8552 for international ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2
... WARSAW, Ind., Oct. 3, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
... In a presentation at the Congress of Neurological Surgeons ... reported that preliminary results of a pilot clinical trial ... safely and effectively control essential tremor (ET), a common ... Results from the study,s first 10 patients showed ...
Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results 2Focused Ultrasound Shows Promise as a Noninvasive Deep Brain Treatment for Essential Tremor, a Condition That Affects Millions 2Focused Ultrasound Shows Promise as a Noninvasive Deep Brain Treatment for Essential Tremor, a Condition That Affects Millions 3Focused Ultrasound Shows Promise as a Noninvasive Deep Brain Treatment for Essential Tremor, a Condition That Affects Millions 4
(Date:7/28/2014)... 2014 In The Tainted ... market to a disadvantaged consumer base, be ... proven, often offensive, ethnically-slanted advertisements to bombard ... Tainted Burger." Amazon: http://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Daps&field-keywords=tainted%20burger .) ... author and activist who says, "So what ...
(Date:7/27/2014)... July 27, 2014 Manufacturers of natural ... organic ways to achieve a younger appearance. The Cherry ... guide to help men and women explore the availabilities ... details that are presented in the posted guide on ... information for consumers. On drawback to some natural ingredient ...
(Date:7/27/2014)... Ticket Down is a reputable source for ... Inglewood, California on November 15th. This Australian boy band has ... hear songs from this amazing album at the concert. , ... at The Forum will be released for sale to the general ... time TicketDown.com. This popular secondary ticket exchange can also be ...
(Date:7/27/2014)... The constant expansion of companies across ... for enterprise video. Additional factors that have increased this ... such as corporate communication, learning and development, security and ... these factors the enterprise video market value has crossed ... $35.57 billion in 2018 with a compound annual growth ...
(Date:7/27/2014)... report, “Oil Filter & Fuel Filter Market by Vehicle ... & Aftermarket), Filter Type (Oil & Fuel), Fuel Type ... Forecast to 2018”, defines and segments the global automotive ... of the global volume and revenue. The market for ... of $6.1 billion in 2018, while fuel filter market ...
Breaking Medicine News(10 mins):Health News:The Tainted Burger- McDonalds's Franchise Owner's Tale by Author Michael B. Potts Says McDonald's Disproportionately Markets to Minorities--Tedx Video Supports Claim 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5
... Automates IBC Protocol Operations and Addresses Medical Research Compliance ... TOPAZ Technologies, a leading provider of medical research management ... latest software addition to its product line, the Biosafety ... the medical research study protocol process, from protocol inception ...
... still needs doctors, interpretation, , , WEDNESDAY, June 10 ... ability -- and which you can give yourself -- ... tests in detecting early dementia, according to British researchers. ... "shows great promise as a screening test for Alzheimer,s ...
... DALLAS, June 10 When he arrived at Methodist Rehabilitation ... by Guillain-Barre Syndrome and barely able to lift his head. ... therapist and the rehabilitation staff, the 48-year-old father of two ... a walker. "My son said that all he wanted for ...
... Biology of Bavituximab and Chemotherapy in Lung Cancer Awarded to ... , - New Study Complements Ongoing Bavituximab Plus Carboplatin/Paclitaxel ... - , , TUSTIN, Calif., June 10 Peregrine ... the ASCO Research Foundation has awarded one of its 2009 ...
... Exclusive Worldwide License to Transdel,s Anti-Cellulite Cosmeceutical Product ... Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) ... licensing agreement providing JH Direct with the exclusive ... utilizes Transdel,s patented transdermal delivery system technology, Transdel(TM). ...
... , LOS ALTOS, Calif., June 10 InteKrin Therapeutics ... American Diabetes Association annual meeting in New Orleans demonstrating ... anti-diabetic efficacy consistent with maximal dose thiazolidinedione (TZD) therapy ... , The 4 week double blind placebo controlled ...
Cached Medicine News:Health News:TOPAZ Technologies Introduces Biosafety Software Solution 2Health News:TOPAZ Technologies Introduces Biosafety Software Solution 3Health News:Questionnaire May Help Spot Early Dementia 2Health News:Questionnaire May Help Spot Early Dementia 3Health News:Former Quadriplegic Patient Able to Walk Out of Methodist Rehabilitation Hospital 2Health News:ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer 2Health News:ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer 3Health News:ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer 4Health News:Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product 2Health News:Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product 3Health News:Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product 4Health News:InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting 2Health News:InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting 3
... for the quantitative determination of ... kinetic, lag phase of less ... linear phase of at least ... Linearity: 100 mg/dL (35.6 mmol/L ...
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
... the first microplate spectrophotometer designed specifically to ... per week. With rugged hardware, proven optical ... the barrier of traditional spectrophotometry to obtain ... can easily read up to eight, 1 ...
The PerkinElmer LS 45 Luminescence spectrometer offers versatility, reliability and ease-of-use for routine analyses in an affordable package....
Medicine Products: